Advanced search
Publication Cover
Leukemia & Lymphoma Volume 30, 1998 - Issue 5-6
Submit an article Journal homepage
28
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Cladribine for Untreated or Early Low-Grade Non-Hodgkin's Lymphoma

Jan Liliemark Department of Oncology, Karolinska Hospital, S-171 76, Stockholm
,
Ulla Martinsson Department of Oncology, Akademiska Hospital, S-781 85, Uppsala
,
Eva Cavallin Ståhlc Department of Oncology, University Hospital, S-461 85, Lund
,
Erik Svedmyr Department of Oncology, Karolinska Hospital, S-171 76, Stockholm
,
Anja Porwit Department of Oncology, Karolinska Hospital, S-171 76, Stockholm
,
Mats Strömberg Department of Pathology, Karolinska Hospital, S-171 76, Stockholm
&
Gunnar Juliusson Department of Haematology, University Hospital, S-581 85, Linköping, Sweden
 show all
Pages 573-581 | Received 10 Oct 1997, Published online: 01 Jul 2009

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Darren S Sigal & Alan Saven. (2008) Cladribine in indolent non-Hodgkin’s lymphoma. Expert Review of Anticancer Therapy 8:4, pages 535-545.
Read now
Jack C Sipe. (2005) Cladribine for multiple sclerosis: review and current status. Expert Review of Neurotherapeutics 5:6, pages 721-727.
Read now
Mathias J. Rummel, Kai U. Chow, Elke Jäger, Lothar Leimer, Deter K. Hossfeld, Lothar Bergmann, Hans D. Peters, Martin L. Hansmann, Annette Meyer, Dieter Hoelzer & Paris S. Mitrou. (1999) Intermittent 2-Hour-Infusion of Cladribine as First-Line Therapy or in First Relapse of Progressive Advanced Low-Grade and Mantle Cell Lymphomas. Leukemia & Lymphoma 35:1-2, pages 129-138.
Read now

Articles from other publishers (14)

Francesco Bertoni, Davide Rossi, Markus Raderer & Emanuele Zucca. (2020) Marginal Zone Lymphomas. The Cancer Journal 26:4, pages 336-347.
Crossref
Darren S. Sigal, Heather J. Miller, Ethan D. Schram & Alan Saven. (2010) Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood 116:16, pages 2884-2896.
Crossref
Daniele LaszloGiovanna AndreolaLuigi RigacciAlberto FabbriCristina RabascioPatrizia MancusoGiancarlo PruneriDavide RadiceAntonello PintoFerdinando FrigeriLiliana CalabreseAtto BillioFrancesco BertoliniGiovanni Martinelli. (2010) Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study. Journal of Clinical Oncology 28:13, pages 2233-2238.
Crossref
Tadeusz Robak, Anna Korycka, Ewa Lech-Maranda & Pawel Robak. (2009) Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases. Molecules 14:3, pages 1183-1226.
Crossref
Andrés J.M. Ferreri & Emanuele Zucca. (2007) Marginal-zone lymphoma. Critical Reviews in Oncology/Hematology 63:3, pages 245-256.
Crossref
Kristie A. Blum, Jeffrey L. Johnson, Donna Niedzwiecki, Lawrence D. Piro, Alan Saven, Bruce A. Peterson, John C. Byrd & Bruce D. Cheson. (2006) Prolonged follow‐up after initial therapy with 2‐chlorodeoxyadenosine in patients with indolent non‐Hodgkin lymphoma. Cancer 107:12, pages 2817-2825.
Crossref
Farhad Ravandi & Susan O’Brien. (2005) Infections associated with purine analogs and monoclonal antibodies. Blood Reviews 19:5, pages 253-273.
Crossref
Wolfgang Hiddemann, Heinz Huber & Claus R. BartramL. Trümper, P. Möller & A. Neubauer. 2004. Die Onkologie. Die Onkologie 1711 1774 .
Pier Luigi Zinzani. (2002) Non-Hodgkin's lymphoma: the evolving role of purine analogues. Best Practice & Research Clinical Haematology 15:3, pages 505-516.
Crossref
M.J Rummel, K.U Chow, T Karakas, E Jäger, J Mezger, U von Grünhagen, K.-P Schalk, O Burkhard, M.-L Hansmann, H Ritzel, L Bergmann, D Hoelzer & P.S Mitrou. (2002) Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma. European Journal of Cancer 38:13, pages 1739-1746.
Crossref
Janice P. DutcherYelena NovikKevin O'BoyleGeorge MarcoullisChristiane SeccoPeter H. Wiernik. (2013) 20th‐Century Advances in Drug Therapy in Oncology—Part I. The Journal of Clinical Pharmacology 40:9, pages 1007-1024.
Crossref
Pierre Soubeyran, Marc Debled, Nadine Tchen, Pierre Richaud, Alain Monnereau, Françoise Bonichon & Houchingue Eghbali. (2000) Follicular lymphomas — a review of treatment modalities. Critical Reviews in Oncology/Hematology 35:1, pages 13-32.
Crossref
Peter McLaughlin. (1999) Treatment of follicular and other indolent lymphomas. Current Opinion in Oncology 11:5, pages 333.
Crossref
M.J. Rummel, K.U. Chow, E. Jäger, D.K. Hossfeld, L. Bergmann, H.-D. Peter, M.-L. Hansmann, A. Meyer, D. Hoelzer & P.S. Mitrou. (1999) Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse. Annals of Oncology 10:1, pages 115-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.